Today’s consumers are active, engaged participants in their health and wellness. Acknowledging this phenomena, the life sciences industry is moving "beyond the pill" to focus on patient-centered solutions; enhancing experience by proving therapeutic value, resolving barriers to treatment access and adherence programs and providing healthcare professionals solutions to improve effectiveness and enhance care. By examining each stage of commercialization through the patient's eyes, aligning with the treatment decision journey and delivering the right mix of services via preferred communication channels, health outcomes can markedly improve.

Enter Signals Analytics, creator of the only cloud-based system of insight that transforms the world’s unconnected data and real world evidence into real time actionable intelligence to enhance therapeutic outcomes, optimize product portfolio health and propel patient-centered innovation. By utilizing Signals Playbook, commercialization executives can uncover a holistic view of patient populations, develop targeted programs based on stakeholder roles and connect offerings to drive superior omnichannel experiences and therapeutic effect.


Within 3 weeks Signals Playbook identified the top acquisition targets across 10 categories, some of whom we were unaware even existed. We immediately moved to due diligence with 16 of them and saved months in the process.”

Head of New Ventures at a Top 5 Consumer Healthcare Company

Impact to Your Business


Assure Product Launch Activities are Congruent with all Stages of the Patient Treatment Journey 

Build, Monitor and Enhance Outcomes-Focused Patient Access and Support Strategies 

Uncover Technology Partnerships for Digital "Beyond the Pill" Value Creation

Increase Adherence and Minimize Substitutions Through Digital Health Ecosystem Management

Improve Omnichannel Patient and Provider Experience to Drive Peak Revenue


A Top 20 Global Life Sciences Company Renovates
a Prominent Drug Portfolio

A leading global pharmaceutical company aimed to close a $200M revenue gap following the acquisition of a new consumer health products portfolio. Within weeks, Signals Playbook modeled global patient populations and their therapeutic needs with 92% greater accuracy than conventional methods, and the company immediately commenced renovation of its global go-to-market strategies.

The Signals Analytics Difference


Precision Intelligence That Matters Most to Your Enterprise

Real Time Signals Detection with Validated Source Data  

Built By Industry Experts For Industry Experts

Rapid Business Impact and Value Right
Out of the

Learning Combined with Human Intelligence


The Latest From Signals Analytics

Let's Talk


Signals Analytics Headquarters
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
(917) 470 9110

Signals Analytics Labs
7 Giborei Israel St.
P.O.B 8374, Netanya 4250407, Israel
+972 73 718 1650

Signals Analytics Europe
Av. de Sécheron 15,
1202 Geneva, Switzerland
+41 22 575 5045

All Offices




General Information:

Inquires or Request a Demo